resveratrol has been researched along with Experimental Neoplasms in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 11 (47.83) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Rabbani, N; Thornalley, PJ | 1 |
| Kim, J; Lee, Y; Shin, H | 1 |
| Guo, L; Long, Q; Pu, L; Zhu, W | 1 |
| Cho, S; Kim, JR; Lim, J; Park, S | 1 |
| Atef, A; Estfanous, RS; Kabel, AM | 1 |
| Kikuchi, H; Kuribayashi, F; Mimuro, H | 1 |
| Karkabounas, SC; Oikonomidis, S; Simos, YV; Toliopoulos, IK | 1 |
| Farazi, M; Goldufsky, J; Linnane, S; Lukaesko, L; Nguyen, J; Ruby, CE; Weinberg, AD | 1 |
| Chen, L; Deng, ZL; He, BC; Huang, J; Liu, Y; Liu, YZ; Luo, JY; Meng, ZJ; Sun, WJ; Wang, DX; Wang, X; Wu, K; Yang, JQ; Yin, LJ; Yuan, SX; Zuo, GW | 1 |
| Chen, X; Dun, J; Gao, H; Zhang, H; Zhang, Y | 1 |
| Ichihara, M; Kawamoto, Y; Kyogashima, M; Mizutani, N; Murate, T; Nakamura, M; Nozawa, Y; Omori, Y; Sobue, S; Suzuki, M; Tamiya-Koizumi, K | 1 |
| Bianchi, L; Cao, Y; Corana, F; Ferraro, D; Jensen, LD; Maccario, C; Mannucci, B; Savio, M; Stivala, LA; Vaccarone, R | 1 |
| Choudhary, B; Gopalakrishnan, V; Hegde, M; Karki, SS; Kumar, S; Raghavan, SC; Thomas, E | 1 |
| Boily, G; He, XH; Jardine, K; McBurney, MW; Pearce, B | 1 |
| El-Awady, el-S; El-Azab, M; Hishe, H; Moustafa, Y | 1 |
| Russell, ST; Tisdale, MJ; Wyke, SM | 1 |
| Stein, JM; Ulrich, S; Wolter, F | 1 |
| Hirose, M; Ishii, Y; Kanki, K; Kitamura, Y; Kuroiwa, Y; Nishikawa, A; Umemura, T | 1 |
| Ametller, E; Argilés, JM; Busquets, S; Carbó, N; Costelli, P; Figueras, M; Fuster, G; López-Soriano, FJ; Olivan, M | 1 |
| Fan, GX; Li, T; Wang, W; Yuan, YK | 1 |
| Cho, D; Cho, JA; Kim, CW; Paik, JH; Yang, Y | 1 |
| Beecher, CW; Cai, L; Farnsworth, NR; Fong, HH; Jang, M; Kinghorn, AD; Mehta, RG; Moon, RC; Pezzuto, JM; Slowing, KV; Thomas, CF; Udeani, GO | 1 |
| Surh, Y | 1 |
3 review(s) available for resveratrol and Experimental Neoplasms
| Article | Year |
|---|---|
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Induction; Glutathione; Glycosylation; Hesperidin; Humans; Insulin Resistance; Lactoylglutathione Lyase; Mice; Molecular Structure; Neoplasms, Experimental; Obesity; Pyruvaldehyde; Resveratrol | 2022 |
Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Cycle; Cell Division; Humans; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasms, Experimental; Neovascularization, Pathologic; Resveratrol; Signal Transduction; Stilbenes; Tumor Cells, Cultured | 2005 |
Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances.
Topics: Animals; Capsaicin; Catechin; Catechols; Curcumin; Diet; Fatty Alcohols; Humans; Mice; Neoplasms; Neoplasms, Experimental; Phenols; Plants, Edible; Plants, Medicinal; Resveratrol; Stilbenes | 1999 |
20 other study(ies) available for resveratrol and Experimental Neoplasms
| Article | Year |
|---|---|
In vivo Anti-Cancer Effects of Resveratrol Mediated by NK Cell Activation.
Topics: Animals; Antineoplastic Agents; Cytotoxicity, Immunologic; Female; Humans; Immunity, Innate; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Lysosomal-Associated Membrane Protein 1; Melanoma, Experimental; Mice; Natural Cytotoxicity Triggering Receptor 3; Neoplasm Metastasis; Neoplasms, Experimental; NK Cell Lectin-Like Receptor Subfamily K; Nutrients; Resveratrol; Tumor Burden | 2021 |
RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Oligopeptides; Ovarian Neoplasms; Resveratrol; Serum Albumin, Human | 2020 |
Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cyclin D1; Hepatitis B virus; Humans; Inhibitor of Apoptosis Proteins; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Repressor Proteins; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Survivin; Trans-Activators; Viral Regulatory and Accessory Proteins | 2017 |
Ameliorative potential of sitagliptin and/or resveratrol on experimentally-induced clear cell renal cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Carcinoma, Renal Cell; Immunohistochemistry; Kidney Function Tests; Kidney Neoplasms; Male; Neoplasms, Experimental; Rats; Rats, Wistar; Resveratrol; Sitagliptin Phosphate; Stilbenes | 2018 |
Resveratrol strongly enhances the retinoic acid-induced superoxide generating activity via up-regulation of gp91-phox gene expression in U937 cells.
Topics: Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; NADPH Oxidase 2; Neoplasms, Experimental; Resveratrol; Stilbenes; Superoxides; Tretinoin; U937 Cells; Up-Regulation | 2018 |
Resveratrol diminishes platelet aggregation and increases susceptibility of K562 tumor cells to natural killer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Communication; Dose-Response Relationship, Drug; Humans; K562 Cells; Killer Cells, Natural; Neoplasms, Experimental; Platelet Aggregation; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes; Treatment Outcome | 2013 |
Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging.
Topics: Adoptive Transfer; Aging; Animals; Anticarcinogenic Agents; Blotting, Western; Caloric Restriction; CD4-Positive T-Lymphocytes; Female; Flow Cytometry; Humans; Immunotherapy; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Receptors, OX40; Resveratrol; Stilbenes; Survival Rate; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory | 2014 |
The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Mice, Nude; Neoplasms, Experimental; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; Stilbenes; Xenograft Model Antitumor Assays | 2014 |
Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Fluorouracil; Humans; Mice; Neoplasms, Experimental; Resveratrol; S Phase; Skin Neoplasms; Stilbenes | 2015 |
Resveratrol-induced transcriptional up-regulation of ASMase (SMPD1) of human leukemia and cancer cells.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Neoplasms, Experimental; Resveratrol; Sphingomyelin Phosphodiesterase; Stilbenes; Transcriptional Activation; Up-Regulation | 2016 |
Resveratrol analogue 4,4'-dihydroxy-trans-stilbene potently inhibits cancer invasion and metastasis.
Topics: Animals; Apoptosis; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Male; Mice; Neoplasm Invasiveness; Neoplasms, Experimental; Resveratrol; Stilbenes; Xenograft Model Antitumor Assays | 2016 |
A Novel Resveratrol Based Tubulin Inhibitor Induces Mitotic Arrest and Activates Apoptosis in Cancer Cells.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzene Derivatives; Cell Line, Tumor; Cells, Cultured; G2 Phase Cell Cycle Checkpoints; HEK293 Cells; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mitosis; Neoplasms; Neoplasms, Experimental; Polymerization; Resveratrol; Stilbenes; Tubulin; Tubulin Modulators | 2016 |
SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Blood Vessels; Carcinogens; Cell Transformation, Neoplastic; Female; Genotype; Immunohistochemistry; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Neoplasms, Experimental; NIH 3T3 Cells; Resveratrol; Sirtuin 1; Sirtuins; Skin Neoplasms; Stilbenes; Tetradecanoylphorbol Acetate; Transfection | 2009 |
Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Curcumin; Mice; Neoplasms, Experimental; Neovascularization, Pathologic; Resveratrol; Stilbenes; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
Topics: Animals; Blood Proteins; Cachexia; Cells, Cultured; Chymotrypsin; Curcumin; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Inhibitors; I-kappa B Proteins; Male; Mice; Mice, Inbred Strains; Muscle Fibers, Skeletal; Muscle, Skeletal; Neoplasms, Experimental; NF-kappa B; NF-KappaB Inhibitor alpha; Proteasome Endopeptidase Complex; Proteoglycans; Resveratrol; Stilbenes; Ubiquitins; Weight Loss | 2004 |
Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Carcinogenicity Tests; Carcinogens; Cell Transformation, Neoplastic; Cricetinae; Cyclooxygenase 2; Diet; Injections, Subcutaneous; Isothiocyanates; Male; Membrane Proteins; Mesocricetus; Neoplasms, Experimental; Nitrosamines; Pancreatic Neoplasms; Resveratrol; Stilbenes; Sulfoxides; Thiocyanates | 2006 |
Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models.
Topics: Animals; Body Weight; Cachexia; Carcinoma, Lewis Lung; Disease Models, Animal; Energy Intake; Fish Oils; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Muscle, Skeletal; Neoplasms, Experimental; NF-kappa B; Organ Size; Random Allocation; Rats; Rats, Wistar; Resveratrol; Sarcoma, Yoshida; Stilbenes | 2007 |
Resveratrol induces apoptosis, influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; BALB 3T3 Cells; Cell Line, Tumor; Interleukin-6; Leukemia, Lymphoid; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Resveratrol; Stilbenes | 2007 |
Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells.
Topics: Animals; Cells, Cultured; Female; Forkhead Transcription Factors; Immunosuppressive Agents; Interferon-gamma; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms, Experimental; Resveratrol; Stilbenes; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2008 |
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antimutagenic Agents; Carcinogens; Cell Differentiation; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Female; Fruit; Humans; Inflammation; Isoenzymes; Mammary Neoplasms, Experimental; Membrane Proteins; Mice; Neoplasms, Experimental; Peroxidases; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Resveratrol; Skin Neoplasms; Stilbenes; Tumor Cells, Cultured | 1997 |